ストックスクリーナーアプリを入手
15.95
6.18%
-1.05
アフターアワーズ：
15.88
-0.07
-0.44%
Wave Life Sciences Ltd (WVE) 最新ニュース
Wave Life Sciences stock tumbles 8.5% in first 2026 session as traders refocus on next WVE-007 readout - ts2.tech
WAVE Life Sciences (NASDAQ:WVE) Stock Price Down 7.1%Here's What Happened - MarketBeat
Wave Life Sciences (WVE) Emerges as Obesity Treatment Contender, Oppenheimer Boosts Price Target - Finviz
WAVE Life Sciences Positioned Within Nasdaq Index Biotech Innovation - Kalkine Media
Moody Aldrich Partners LLC Lowers Stock Holdings in WAVE Life Sciences Ltd. $WVE - MarketBeat
15 Best Stocks Under $25 to Buy Now - Insider Monkey
Wave Life Sciences’ (WVE) RNA Obesity Drug WVE-007 Shows Potential to Match GLP-1 Efficacy Without Muscle Loss - Yahoo Finance
H.C. Wainwright Maintains A Buy Rating On Wave Life Sciences Ltd. (WVE) - Finviz
Mid Cap Stocks To Watch TodayDecember 8th - MarketBeat
Voya Investment Management LLC Raises Stock Position in WAVE Life Sciences Ltd. $WVE - MarketBeat
WAVE Life Sciences Ltd. (NASDAQ:WVE) Given Consensus Rating of "Moderate Buy" by Analysts - MarketBeat
Wave Life Sciences (WVE) Stock Today: Obesity Drug Catalyst, $402.5M Financing, and What Investors Are Watching Next - ts2.tech
WAVE Life Sciences (STU:1U5) EV-to-OCF : -14.67 (As of Dec. 25, 2025) - GuruFocus
What New Catalysts Are Rewriting the Narrative for Wave Life Sciences? - Yahoo Finance
Behavioral Patterns of WVE and Institutional Flows - Stock Traders Daily
Wave Life Sciences (WVE) Is Up 11.7% After Early WVE-007 Fat-Loss DataWhat's Changed - simplywall.st
Wave Life Sciences (WVE) Stock: December 24, 2025 News Roundup, Analyst Forecasts, and What Investors Are Watching Next - ts2.tech
Oppenheimer and Truist lift Wave Life Sciences Ltd. (WVE) price targets after positive trial - MSN
Best Biotech Stocks To Keep An Eye OnDecember 8th - MarketBeat
Oppenheimer and Truist Lift Wave Life Sciences Ltd. (WVE) Price Targets After Positive Trial - Insider Monkey
WAVE Life Sciences (NASDAQ:WVE) Stock Price Up 9.5%Still a Buy? - MarketBeat
7 Most Promising Gene Editing Stocks According to Analysts - Insider Monkey
Analysts Offer Predictions for WVE Q1 Earnings - MarketBeat
Wave Life Sciences (WVE) price target increased by 60.82% to 32.70 - MSN
Wave Life Sciences (WVE) Price Target Increased by 60.82% to 32.70 - Nasdaq
Dividend Watch: Is Wave Life Sciences Ltd. stock attractive for income investorsWeekly Profit Analysis & Weekly Watchlist for Hot Stocks - ulpravda.ru
Promising Biotech Stocks To Keep An Eye OnDecember 9th - MarketBeat
HC Wainwright & Co. Maintains Wave Life Sciences (WVE) Buy Recommendation - Nasdaq
WVE: HC Wainwright Raises Price Target to $30, Maintains Buy Rat - GuruFocus
Wave Life Sciences surges as obesity data reshapes long-term outlook - S&P Global
Market Catalysts: Is Wave Life Sciences Ltd. stock a smart buy before Fed meetingJuly 2025 PostEarnings & Stepwise Trade Execution Plans - Bölüm Sonu Canavarı
Will Wave Life Sciences Ltd. stock outperform tech sector in 2025Earnings Overview Report & Weekly Consistent Profit Watchlists - DonanımHaber
Is Wave Life Sciences Ltd. (1U5) stock positioned for digital growth era2025 Technical Overview & Consistent Profit Focused Trading Strategies - DonanımHaber
Will Wave Life Sciences Ltd. stock maintain growth storyPortfolio Update Report & Weekly Breakout Watchlists - Улправда
Is Wave Life Sciences Ltd. stock a smart buy before Fed meetingRate Cut & Low Volatility Stock Recommendations - DonanımHaber
Will Wave Life Sciences Ltd. stock keep outperforming rivalsJuly 2025 Analyst Calls & Stock Portfolio Risk Management - Улправда
Wave Life Sciences (WVE): Valuation Check After Positive WVE-007 Obesity Data And GlaxoSmithKline Backing - simplywall.st
Why Wave Life Sciences Ltd. stock is rated strong buy2025 Market Outlook & Safe Entry Point Identification - Улправда
Wave Life Sciences (WVE) Stock News Today (Dec. 18, 2025): Why Shares Are Sliding, New Analyst Targets, and the Next Catalysts After WVE-007 Obesity Data - ts2.tech
WAVE Life Sciences (NASDAQ:WVE) Shares Down 4.3%Here's Why - MarketBeat
CEO Moves: Is Wave Life Sciences Ltd stock supported by innovation pipeline2025 Market Trends & Step-by-Step Trade Execution Guides - moha.gov.vn
Wave Life Sciences (WVE) Is Down 19.2% After $350 Million Equity Raise On Obesity DataWhat's Changed - simplywall.st
Wave Life Sciences drops after trial data for GSK-partnered RNA-editing therapy - MSN
Share Offerings Prompt Huge Insider Buying in These 3 Biotechs - AOL.com
United StatesMintz Advises On Wave Life Sciences $402.5 Million Public Offering - Mondaq
Oppenheimer Maintains Wave Life Sciences (WVE) Outperform Recommendation - Nasdaq
Oppenheimer raises WAVE Life Sciences stock price target to $32 on WVE-007 data By Investing.com - Investing.com South Africa
Medical Stocks To Watch TodayDecember 8th - MarketBeat
WAVE Life Sciences (NASDAQ:WVE) Shares Gap Up Following Insider Buying Activity - MarketBeat
Oppenheimer Raises Price Target for WAVE Life Sciences (WVE) | W - GuruFocus
Wave Life Sciences (WVE) Stock News Today: Oppenheimer Lifts Target to $32 as WVE-007 Obesity Data Fuels Volatility - ts2.tech
Wave Life (WVE) shares nearly triple on encouraging obesity drug trial - MSN
Subdued Growth No Barrier To Wave Life Sciences Ltd. (NASDAQ:WVE) With Shares Advancing 128% - simplywall.st
Oppenheimer raises WAVE Life Sciences stock price target to $32 on WVE-007 data - Investing.com India
Obesity data, Kymera and FDA sentiment survey results — a BioCentury podcast - BioCentury
WAVE Life Sciences (NASDAQ:WVE) Major Shareholder Purchases 1,470,000 Shares - MarketBeat
Wave Life Sciences’ Obesity Drug Draws $10 Billion Expectations - Finimize
0.57%
大文字化:
|
ボリューム (24 時間):